Ivan Kruljac
Impact in
-
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
Papers in
- Oncology 8
- Lung Cancer Research Studies 4
-
- Diabetes Management and Research 2
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Co-authors
- Milan Vrkljan (10 shared papers)Mario Štefanović (7 shared papers)Hrvoje Ivan Pećina (2 shared papers)Ivana Ćelap (1 shared paper)Marko Lucijanić (1 shared paper)Ulrich‐Frank Pape (2 shared papers)Leo Pažanin (1 shared paper)Darko Kaštelan (1 shared paper)
- Journals
- Scientific Reports (1 paper)Endocrine Research (1 paper)Neuroendocrinology (1 paper)Journal of Clinical Oncology (1 paper)Endocrine Pathology (1 paper)
- Partner nations
- CroatiaItalyUnited Kingdom
In The Last Decade
Ivan Kruljac
24 papers receiving 181 citations
Peers
Comparison fields: 5 of 50
- Endocrinology, Diabetes and Metabolism 55
- Otorhinolaryngology 12
- Oncology 60
- Orthopedics and Sports Medicine 14
- Cardiology and Cardiovascular Medicine 25
Countries citing papers authored by Ivan Kruljac
This map shows the geographic impact of Ivan Kruljac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Kruljac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Kruljac more than expected).
Fields of papers citing papers by Ivan Kruljac
This network shows the impact of papers produced by Ivan Kruljac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Kruljac. The network helps show where Ivan Kruljac may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Kruljac, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 28 | |
| 2 | 2016 | 24 | |
| 3 | 2015 | 20 | |
| 4 | 2016 | 19 | |
| 5 | 2019 | 13 | |
| 6 | 2012 | 13 | |
| 7 | 2015 | 9 | |
| 8 | 2017 | 8 | |
| 9 | 2021 | 7 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 4 | |
| 13 | 2018 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2016 | 3 | |
| 18 | 2018 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2018 | 1 |
About Ivan Kruljac
Ivan Kruljac is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology and Genetics, having authored 25 papers that have together received 183 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Diabetes and associated disorders (4 papers), Lung Cancer Research Studies (4 papers), Advanced Radiotherapy Techniques (3 papers), Bone health and osteoporosis research (2 papers), Diabetes Management and Research (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers) and Prostate Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (55 citations), Otorhinolaryngology (12 citations), Oncology (60 citations), Orthopedics and Sports Medicine (14 citations) and Cardiology and Cardiovascular Medicine (25 citations). Ivan Kruljac has collaborated with scholars based in Croatia, Italy and United Kingdom. Frequent co-authors include Milan Vrkljan, Mario Štefanović, Hrvoje Ivan Pećina, Ivana Ćelap, Marko Lucijanić, Ulrich‐Frank Pape, Leo Pažanin, Darko Kaštelan, Velimir Božikov and Tajana Pavić. Their work appears in journals such as Scientific Reports, Endocrine Research, Neuroendocrinology, Journal of Clinical Oncology and Endocrine Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.